DexCom CFO Departs; Interim Appointed, New Directors Elected
Ticker: DXCM · Form: 8-K · Filed: Sep 16, 2025 · CIK: 1093557
| Field | Detail |
|---|---|
| Company | Dexcom INC (DXCM) |
| Form Type | 8-K |
| Filed Date | Sep 16, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-departure, board-changes, interim-cfo
Related Tickers: DXCM
TL;DR
CFO OUT, interim IN. New board members join. #leadershipchange
AI Summary
DexCom, Inc. announced on September 14, 2025, the departure of its Chief Financial Officer, Parth Desai. The company has appointed Jerrod Hill as the interim CFO. Additionally, the board of directors has elected two new independent directors, Kevin J. McNamara and Steven J. Shulman, effective September 14, 2025.
Why It Matters
The departure of a CFO and the appointment of new directors can signal changes in financial strategy or governance, impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Changes in key executive positions and board composition can introduce uncertainty regarding future strategy and financial management.
Key Players & Entities
- DexCom, Inc. (company) — Registrant
- Parth Desai (person) — Departing Chief Financial Officer
- Jerrod Hill (person) — Interim Chief Financial Officer
- Kevin J. McNamara (person) — Newly Elected Independent Director
- Steven J. Shulman (person) — Newly Elected Independent Director
- September 14, 2025 (date) — Effective date of changes
FAQ
Who has been appointed as the interim Chief Financial Officer of DexCom, Inc.?
Jerrod Hill has been appointed as the interim Chief Financial Officer.
When was the departure of Parth Desai as CFO announced?
The departure was reported as of September 14, 2025.
Who are the new independent directors elected to DexCom's board?
Kevin J. McNamara and Steven J. Shulman have been elected as new independent directors.
What is DexCom, Inc.'s principal executive office address?
DexCom, Inc.'s principal executive offices are located at 6340 Sequence Drive, San Diego, CA 92121.
What is the exact date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is September 14, 2025.
Filing Stats: 570 words · 2 min read · ~2 pages · Grade level 10.8 · Accepted 2025-09-15 19:30:47
Key Financial Figures
- $0.001 — ange on Which Registered Common Stock, $0.001 Par Value Per Share DXCM Nasdaq Global
Filing Documents
- dxcm-20250914.htm (8-K) — 25KB
- dxcm-20250914_g1.jpg (GRAPHIC) — 108KB
- 0001093557-25-000257.txt ( ) — 386KB
- dxcm-20250914.xsd (EX-101.SCH) — 2KB
- dxcm-20250914_lab.xml (EX-101.LAB) — 21KB
- dxcm-20250914_pre.xml (EX-101.PRE) — 12KB
- dxcm-20250914_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. DEXCOM, INC. By: /s/ JEREME M. SYLVAIN Jereme M. Sylvain Executive Vice President, Chief Financial Officer Date: September 15, 2025